This announcement is a separate document:
红日药业：天津红日药业股份有限公司2021年面向专业投资者公开发行公司债券（第一期）受托管理事务报告（2023年度）
Tianjin Chase Sun Pharmaceutical: CSI Enterprise Bond Index's Tianjin Chase Sun Pharmaceutical publicly issued corporate bonds (first phase) for professional investors in 2021. This report is for the entrusted management affairs (2023).
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.